156 related articles for article (PubMed ID: 21156319)
1. Oxidized LDL immune complexes and coronary artery calcification in type 1 diabetes.
Lopes-Virella MF; Baker NL; Hunt KJ; Lachin J; Nathan D; Virella G;
Atherosclerosis; 2011 Feb; 214(2):462-7. PubMed ID: 21156319
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
[TBL] [Abstract][Full Text] [Related]
3. High levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetes.
Lopes-Virella MF; Carter RE; Baker NL; Lachin J; Virella G;
Nephrol Dial Transplant; 2012 Apr; 27(4):1416-23. PubMed ID: 21856760
[TBL] [Abstract][Full Text] [Related]
4. Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes.
Lopes-Virella MF; Hunt KJ; Baker NL; Lachin J; Nathan DM; Virella G;
Diabetes; 2011 Feb; 60(2):582-9. PubMed ID: 20980456
[TBL] [Abstract][Full Text] [Related]
5. Proatherogenic and proinflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL.
Virella G; Atchley D; Koskinen S; Zheng D; Lopes-Virella MF;
Clin Immunol; 2002 Oct; 105(1):81-92. PubMed ID: 12483997
[TBL] [Abstract][Full Text] [Related]
6. Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes.
Hunt KJ; Baker N; Cleary P; Backlund JY; Lyons T; Jenkins A; Virella G; Lopes-Virella MF;
Atherosclerosis; 2013 Dec; 231(2):315-22. PubMed ID: 24267245
[TBL] [Abstract][Full Text] [Related]
7. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A
Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
[TBL] [Abstract][Full Text] [Related]
8. Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study.
Fährmann ER; Adkins L; Loader CJ; Han H; Rice KM; Denvir J; Driscoll HK
Diabetes Res Clin Pract; 2015 Feb; 107(2):280-9. PubMed ID: 25467622
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study.
Orchard TJ; Virella G; Forrest KY; Evans RW; Becker DJ; Lopes-Virella MF
Diabetes; 1999 Jul; 48(7):1454-8. PubMed ID: 10389853
[TBL] [Abstract][Full Text] [Related]
10. High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes.
Lopes-Virella MF; Baker NL; Hunt KJ; Lyons TJ; Jenkins AJ; Virella G;
Diabetes Care; 2012 Jun; 35(6):1333-40. PubMed ID: 22511260
[TBL] [Abstract][Full Text] [Related]
11. Anti-modified LDL antibodies and LDL-containing immune complexes in IDDM patients and healthy controls.
Mironova M; Virella G; Virella-Lowell I; Lopes-Virella MF
Clin Immunol Immunopathol; 1997 Oct; 85(1):73-82. PubMed ID: 9325072
[TBL] [Abstract][Full Text] [Related]
12. The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
Cleary PA; Orchard TJ; Genuth S; Wong ND; Detrano R; Backlund JY; Zinman B; Jacobson A; Sun W; Lachin JM; Nathan DM;
Diabetes; 2006 Dec; 55(12):3556-65. PubMed ID: 17130504
[TBL] [Abstract][Full Text] [Related]
13. The role of coronary artery calcification testing in incident coronary artery disease risk prediction in type 1 diabetes.
Guo J; Erqou SA; Miller RG; Edmundowicz D; Orchard TJ; Costacou T
Diabetologia; 2019 Feb; 62(2):259-268. PubMed ID: 30426170
[TBL] [Abstract][Full Text] [Related]
14. Association of apolipoprotein A phenotypes and oxidized low-density lipoprotein immune complexes in children.
Islam S; Gutin B; Treiber F; Hobbs G; Kamboh I; Lopes-Virella M
Arch Pediatr Adolesc Med; 1999 Jan; 153(1):57-62. PubMed ID: 9895000
[TBL] [Abstract][Full Text] [Related]
15. Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathy.
Atchley DH; Lopes-Virella MF; Zheng D; Kenny D; Virella G
Diabetologia; 2002 Nov; 45(11):1562-71. PubMed ID: 12436340
[TBL] [Abstract][Full Text] [Related]
16. Immune Complexes and the Risk of CVD in Type 1 Diabetes.
Lopes-Virella MF; Bebu I; Hunt KJ; Virella G; Baker NL; Braffett B; Gao X; Lachin JM;
Diabetes; 2019 Sep; 68(9):1853-1860. PubMed ID: 31217176
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of coronary calcium score by multidetector computed tomography in relation to endothelial function and inflammatory markers in asymptomatic individuals.
Ramadan MM; Mahfouz EM; Gomaa GF; El-Diasty TA; Alldawi L; Ikrar T; Limin D; Kodama M; Aizawa Y
Circ J; 2008 May; 72(5):778-85. PubMed ID: 18441459
[TBL] [Abstract][Full Text] [Related]
18. Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes.
Wadwa RP; Kinney GL; Ogden L; Snell-Bergeon JK; Maahs DM; Cornell E; Tracy RP; Rewers M
Int J Biochem Cell Biol; 2006; 38(5-6):996-1003. PubMed ID: 16271309
[TBL] [Abstract][Full Text] [Related]
19. Coronary Artery Calcium Score for Long-term Risk Classification in Individuals With Type 2 Diabetes and Metabolic Syndrome From the Multi-Ethnic Study of Atherosclerosis.
Malik S; Zhao Y; Budoff M; Nasir K; Blumenthal RS; Bertoni AG; Wong ND
JAMA Cardiol; 2017 Dec; 2(12):1332-1340. PubMed ID: 29117273
[TBL] [Abstract][Full Text] [Related]
20. Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study.
Dabelea D; Kinney G; Snell-Bergeon JK; Hokanson JE; Eckel RH; Ehrlich J; Garg S; Hamman RF; Rewers M;
Diabetes; 2003 Nov; 52(11):2833-9. PubMed ID: 14578303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
